查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613386

数位病理检测市场：按产品类型、应用和最终用户划分 - 全球预测 2025-2030

Digital Pathology Market by Product (Scanners, Software, Storage Systems), Type (Human Pathology, Veterinary Pathology), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年数位病理检测市场价值为18.5亿美元，预计到2024年将达到21.1亿美元，复合年增长率为14.58%，到2030年将达到48.1亿美元。

数位病理学是指在数位环境中捕获、管理和解释病理资讯的实践。该领域包括基于影像的资讯环境，利用技术将载玻片转换为数位影像。数位病理学测试的需求在于其能够提高诊断准确性、简化工作流程并实现更有效率的资料储存和搜寻过程。它具有广泛的用途，包括远端病理学、药物发现、教育和初步诊断，可用于实验室、医院、製药公司、学术机构等。数位病理学测试的最终用途包括医疗机构、研究机构和生物技术公司利用该技术来提高诊断准确性和推进研究。

主要市场统计
基准年[2023] 18.5亿美元
预计年份 [2024] 21.1亿美元
预测年份 [2030] 48.1亿美元
复合年增长率（%） 14.58%

根据市场洞察，在慢性病盛行率上升、个人化医疗需求以及影像分析技术进步的推动下，数位病理检测正在经历强劲成长。关键的成长要素包括在病理测试中更多地采用人工智慧和机器学习、转向基于价值的医学以及病理实验室数位平台的整合。最新的机会包括云端基础的病理学服务以及扩展到开拓的市场，在这些市场中，数位病理学测试可以显着改善医疗保健的可近性。然而，挑战依然存在，包括实施成本高、缺乏标准化以及对资料安全和病患隐私的担忧。

创新和研究的机会已经成熟，包括开发更便宜的数位幻灯片扫描器、利用人工智慧增强诊断工具以及建立病理影像的综合资料库。公司应专注于与高科技公司合作，推动创新并最大限度地降低成本，以提高采用率。该市场的特点是技术快速进步和竞争格局要求企业不断创新和差异化。总之，数位病理测试在改变医疗保健服务和诊断方面具有巨大潜力，但必须解决财务、监管和隐私挑战才能实现市场的持续成长。

市场动态：快速发展的数位病理测试市场的关键市场洞察

数位病理检测市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性病盛行率增加
    • 更多地采用数位病理学测试以提高实验室效率
    • 医疗保健 IT 解决方案在研究领域的渗透率不断提高
  • 市场限制因素
    • 引进数位病理检测需高额资本投入
  • 市场机会
    • 融合人工智慧和巨量资料分析，改善病理医师的工作站体验
    • 公司之间的策略联盟和协议，以实施有效的投资组合
  • 市场挑战
    • 数位病理检测缺乏标记资料和法律障碍

波特五力：驾驭数位病理检测市场的策略工具

波特的五力框架是了解数位病理测试市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对数位病理检测市场的影响

外部宏观环境因素在塑造数位病理检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解数位病理检测市场的竞争状况

数位病理测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵数位病理检测市场供应商绩效评估

FPNV定位矩阵是评估数位病理检测市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了数位病理检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对数位病理检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病流行
      • 更多地采用数位病理学测试以提高实验室效率
      • 医疗保健 IT 解决方案在研究中的扩展
    • 抑制因素
      • 实施数位病理检测需要大量资本投资
    • 机会
      • 整合人工智慧和巨量资料分析，改善病理学家的工作站体验
      • 公司之间的策略伙伴关係和协议，以有效引入产品组合
    • 任务
      • 数位病理检测缺乏标记资料和法律障碍
  • 市场区隔分析
    • 产品：越来越多地转向云端基础的解决方案，以获得更灵活、更具成本效益的储存选项
    • 应用：更多地采用数位病理学测试，以提高识别潜在治疗标靶和了解疾病机制的速度和准确性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章数位病理测试市场：依产品

  • 扫描器
  • 软体
  • 储存系统

第七章数字病理测试市场：按类型

  • 人类病理学
  • 兽医病理学

第八章数位病理检测市场：依应用分类

  • 疾病诊断
  • 药物发现
  • 教育和培训

第九章数位病理测试市场：依最终用户分类

  • 学术研究所
  • 医院和研究机构
  • 製药和生物技术公司

第十章美洲数位病理检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太数字病理检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲数位病理检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Proscia 和 Pramana, Inc. 合作透过先进的人工智慧和成像技术改进数位病理学测试
    • Ibex Medical Analytics 与 PathPresenter 之间的策略合作伙伴关係加强了人工智慧驱动的数位病理学测试的采用
    • 罗氏组织诊断和 PathAI 增强人工智慧驱动的伴同性诊断
  • 战略分析和建议

公司名单

  • 3DHISTECH Ltd.
  • Aiforia Technologies PLC
  • Charles River Laboratories
  • Corista LLC
  • DeepBio, Inc.
  • Epredia
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hamamatsu Photonics KK
  • Huron Digital Pathology
  • Indica Labs
  • Koninklijke Philips NV
  • Laboratory Corporation of America Holdings
  • Leica Biosystems Nussloch GmbH
  • Mikroscan Technologies
  • Motic
  • Nikon Corporation
  • OptraSCAN, Inc.
  • PathAI
  • Pathcore Inc.
  • PathPresenter Corporation
  • PerkinElmer, Inc.
  • Proscia, Inc.
  • Sectra AB
  • Visiopharm A/S
  • Xybion Digital Inc.
Product Code: MRR-433498411CFD

The Digital Pathology Market was valued at USD 1.85 billion in 2023, expected to reach USD 2.11 billion in 2024, and is projected to grow at a CAGR of 14.58%, to USD 4.81 billion by 2030.

Digital pathology refers to the practice of acquiring, managing, and interpreting pathology information in a digital environment. This field encompasses image-based information environments that utilize technology to convert glass slides into digital images. The necessity of digital pathology lies in its ability to enhance accuracy in diagnostics, streamline workflows, and enable more efficient data storage and retrieval processes. Applications span across telepathology, drug discovery, education, and primary diagnosis, making it invaluable in laboratories, hospitals, pharmaceutical companies, and academic institutions. Digital pathology's end-use scope extends to healthcare institutions, research organizations, and biotech companies that are leveraging this technology for improved diagnostic precision and research advancements.

KEY MARKET STATISTICS
Base Year [2023] USD 1.85 billion
Estimated Year [2024] USD 2.11 billion
Forecast Year [2030] USD 4.81 billion
CAGR (%) 14.58%

Market insights reveal that digital pathology is experiencing robust growth, driven by the rising prevalence of chronic diseases, demand for personalized medicine, and technological advances in image analysis. Key growth factors include increased adoption of AI and machine learning for pathology, the shift towards value-based care, and the integration of digital platforms in pathology labs. Latest opportunities include cloud-based pathology services and the expansion into underserved markets, where digital pathology can significantly improve access to healthcare. However, challenges persist, such as high costs of implementation, lack of standardization, and concerns over data security and patient privacy.

Innovation and research opportunities are ripe in developing more affordable digital slide scanners, enhancing AI-powered diagnostic tools, and creating comprehensive databases for pathology images. Businesses should focus on partnerships with tech companies to drive innovation and on minimizing costs to enhance adoption rates. The market is characterized by rapid technological advancements and a competitive landscape, urging companies to continuously innovate and differentiate. In summary, while digital pathology holds significant promise for transforming healthcare delivery and diagnostics, addressing financial, regulatory, and privacy challenges is essential for sustainable market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Pathology Market

The Digital Pathology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic disease
    • Rising adoption of digital pathology to enhance lab efficiency
    • Increasing penetration of healthcare IT solutions across research
  • Market Restraints
    • High capital investment required for the implementation of digital pathology
  • Market Opportunities
    • Integration of Artificial intelligence and big data analysis to improve the pathologist's workstation experience
    • Strategic partnership and agreement among companies for the introduction of an effective portfolio
  • Market Challenges
    • Lack of labeled data and legal barriers in digital pathology

Porter's Five Forces: A Strategic Tool for Navigating the Digital Pathology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Pathology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Pathology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Pathology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Pathology Market

A detailed market share analysis in the Digital Pathology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Pathology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Pathology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Pathology Market

A strategic analysis of the Digital Pathology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Pathology Market, highlighting leading vendors and their innovative profiles. These include 3DHISTECH Ltd., Aiforia Technologies PLC, Charles River Laboratories, Corista LLC, DeepBio, Inc., Epredia, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GE Healthcare, Hamamatsu Photonics K.K., Huron Digital Pathology, Indica Labs, Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Leica Biosystems Nussloch GmbH, Mikroscan Technologies, Motic, Nikon Corporation, OptraSCAN, Inc., PathAI, Pathcore Inc., PathPresenter Corporation, PerkinElmer, Inc., Proscia, Inc., Sectra AB, Visiopharm A/S, and Xybion Digital Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Scanners, Software, and Storage Systems.
  • Based on Type, market is studied across Human Pathology and Veterinary Pathology.
  • Based on Application, market is studied across Disease Diagnosis, Drug Discovery, and Education & Training.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic disease
      • 5.1.1.2. Rising adoption of digital pathology to enhance lab efficiency
      • 5.1.1.3. Increasing penetration of healthcare IT solutions across research
    • 5.1.2. Restraints
      • 5.1.2.1. High capital investment required for the implementation of digital pathology
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of Artificial intelligence and big data analysis to improve the pathologist's workstation experience
      • 5.1.3.2. Strategic partnership and agreement among companies for the introduction of an effective portfolio
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of labeled data and legal barriers in digital pathology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing shift towards cloud-based solutions for more flexible and cost-effective storage options
    • 5.2.2. Application: Rising adoption of digital pathology to enhance the speed and accuracy of identifying potential therapeutic targets and understanding disease mechanisms
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Pathology Market, by Product

  • 6.1. Introduction
  • 6.2. Scanners
  • 6.3. Software
  • 6.4. Storage Systems

7. Digital Pathology Market, by Type

  • 7.1. Introduction
  • 7.2. Human Pathology
  • 7.3. Veterinary Pathology

8. Digital Pathology Market, by Application

  • 8.1. Introduction
  • 8.2. Disease Diagnosis
  • 8.3. Drug Discovery
  • 8.4. Education & Training

9. Digital Pathology Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Digital Pathology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Digital Pathology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Digital Pathology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Partnership Between Proscia and Pramana, Inc. Elevates Digital Pathology through Advanced AI and Imaging Technologies
    • 13.3.2. Strategic Alliance Between Ibex Medical Analytics and PathPresenter Enhances AI-Powered Digital Pathology Adoption
    • 13.3.3. Roche Tissue Diagnostics and PathAI Enhances AI-Powered Companion Diagnostics
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3DHISTECH Ltd.
  • 2. Aiforia Technologies PLC
  • 3. Charles River Laboratories
  • 4. Corista LLC
  • 5. DeepBio, Inc.
  • 6. Epredia
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. FUJIFILM Holdings Corporation
  • 9. GE Healthcare
  • 10. Hamamatsu Photonics K.K.
  • 11. Huron Digital Pathology
  • 12. Indica Labs
  • 13. Koninklijke Philips N.V.
  • 14. Laboratory Corporation of America Holdings
  • 15. Leica Biosystems Nussloch GmbH
  • 16. Mikroscan Technologies
  • 17. Motic
  • 18. Nikon Corporation
  • 19. OptraSCAN, Inc.
  • 20. PathAI
  • 21. Pathcore Inc.
  • 22. PathPresenter Corporation
  • 23. PerkinElmer, Inc.
  • 24. Proscia, Inc.
  • 25. Sectra AB
  • 26. Visiopharm A/S
  • 27. Xybion Digital Inc.

LIST OF FIGURES

  • FIGURE 1. DIGITAL PATHOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL PATHOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL PATHOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL PATHOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY STORAGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HUMAN PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY VETERINARY PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY EDUCATION & TRAINING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HOSPITALS & LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023